Gallium complexation for DO3A coated nanoparticles: a comprehensive study
1 Ph.D., University of Gezira, Sudan.
2 Assistant professor, Nile Valley University, Sudan.
3 Assistant professor, University if Gezir, Sudan.
4 Assistant professor, King Abdulaziz University, Saudi Arabia.
5 Lecturer, University of TU, Oklahoma.
Review Article
World Journal of Advanced Research and Reviews, 2024, 23(01), 2403–2412
Publication history:
Received on 08 June 2024; revised on 20 July 2024; accepted on 23 July 2024
Abstract:
This review provides a comprehensive review of the synthesis and utilization of DO3A-functionalized NPs (Particularly for MRI and PET/CT analysis). The main focus of the study is the formation of a complex of gallium with NPs coated with DO3A, as well as showing the possibility of improving contrast agents and creating new gallium-based nanomaterials for medical use. The synthesis process studies parameters like pH, temperature, and the effect of substitution of the ligand using various chemical analysis techniques to determine the physicochemical properties of these nano-scale particles. This implies that gallium-loaded NPs have the potential to enhance the fight against infectious diseases, as proved by the NPs' vital role in antimicrobial therapies for PET imaging. Research with animals has shown significant biodistribution to the organs and tissues of interest, which have helped enhance the imaging features of MRI and PET/CT scans. Likewise, the findings on biocompatibility and toxicity point to possible clinical application of these nanoparticles. As for future research directions, the synthesis of other new derivatives of Gd-DO3A complexes containing lipophilic monoamides and the examination of ionization's influence on encapsulation efficiency have been mentioned. This review stresses the promising use of DO3A-coated nanoparticles for nanomedicine as therapeutic agents or imaging probes.
Keywords:
Nanoparticles; DO3A-coated; Gallium and MRI contrast; PET/CT imaging; Biomedical uses; Nanomedicine; Gd-DO3A; Biodistribution; Toxicity; Drug delivery
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0